Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13316781 | 0.95 | MAPK1 (0.41) | MAPK1 | |
| SCHEMBL13316783 | 0.81 | MAPK1 (0.38) | MAPK1 | |
| SCHEMBL137282 | 0.77 | — | — | |
| SCHEMBL7522404 | 0.77 | MAPK1 (0.42) | MAPK1 | |
| SCHEMBL15280690 | 0.77 | MAPK1 (0.37) | MAPK1 | |
| SCHEMBL15280694 | 0.77 | MAPK1 (0.37) | MAPK1 | |
| SCHEMBL723652 | 0.76 | ALDH1A1 (0.38) | — | |
| SCHEMBL212537 | 0.76 | MAPK1 (0.36) | MAPK1 | |
| SCHEMBL19426800 | 0.75 | MAPK1 (0.41) | MAPK1 | |
| SCHEMBL17927986 | 0.75 | MAPK1 (0.41) | MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3543243-B1 | PROCESS FOR THE PREPARATION OF CUCURBITURIL DERIVATIVES | AQDOT LTD (GB) | 2022-02-02 | — | — | EP | claimed |
| US-10626119-B2 | Process for the preparation of cucurbituril and/or one or more derivatives thereof | AQDOT LIMITED (GB) | 2020-04-21 | — | — | US | claimed |
| EP-3543243-A1 | PROCESS FOR THE PREPARATION OF CUCURBITURIL DERIVATIVES | Aqdot Limited (GB) | 2019-09-25 | — | — | EP | claimed |
| US-20190241579-A1 | PROCESS FOR THE PREPARATION OF CUCURBITURIL AND/OR ONE OR MORE DERIVATIVES THEREOF | AQDOT LIMITED (GB) | 2019-08-08 | — | — | US | claimed |
| US-20180244681-A1 | PROCESS | AQDOT LIMITED (GB) | 2018-08-30 | — | — | US | claimed |
| WO-2018115822-A1 | PROCESS FOR THE PREPARATION OF CUCURBITURIL DERIVATIVES | AQDOT LIMITED (GB) | 2018-06-28 | — | — | WO | claimed |
| EP-3543243-B1 | PROCESS FOR THE PREPARATION OF CUCURBITURIL DERIVATIVES | AQDOT LTD (GB) | 2022-02-02 | — | — | EP | disclosed |
| US-10626119-B2 | Process for the preparation of cucurbituril and/or one or more derivatives thereof | AQDOT LIMITED (GB) | 2020-04-21 | — | — | US | disclosed |
| EP-3543243-A1 | PROCESS FOR THE PREPARATION OF CUCURBITURIL DERIVATIVES | Aqdot Limited (GB) | 2019-09-25 | — | — | EP | disclosed |
| US-20190241579-A1 | PROCESS FOR THE PREPARATION OF CUCURBITURIL AND/OR ONE OR MORE DERIVATIVES THEREOF | AQDOT LIMITED (GB) | 2019-08-08 | — | — | US | disclosed |
| EP-3359543-B1 | CUCURBITURIL DERIVATIVES | AQDOT LTD (GB) | 2019-06-26 | — | — | EP | disclosed |
| US-10308657-B2 | Composition comprising cucurbituril and/or one or more derivatives thereof | AQDOT LIMITED (GB) | 2019-06-04 | — | — | US | disclosed |
| US-20180244681-A1 | PROCESS | AQDOT LIMITED (GB) | 2018-08-30 | — | — | US | disclosed |
| US-7378518-B2 | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof | SCHERING CORPORATION (US) | 2008-05-27 | — | — | US | disclosed |
| US-20070155676-A1 | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof | SCHERING CORPORATION (US) | 2007-07-05 | — | — | US | disclosed |
| US-7208486-B2 | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof | SCHERING CORPORATION (US) | 2007-04-24 | — | — | US | disclosed |
| EP-0945445-B9 | 1,5-BENZODIAZEPINE DERIVATIVES | ZERIA PHARM CO LTD (JP) | 2005-12-28 | — | — | EP | disclosed |
| EP-0945445-B1 | 1,5-BENZODIAZEPINE DERIVATIVES | ZERIA PHARM CO LTD (JP) | 2003-09-03 | — | — | EP | disclosed |
| US-6239131-B1 | WHICH HAVE GASTRIN AND/OR CCK-B (CHOLECYSTOKININ-B) RECEPTOR ANTAGONISM, USEFUL AS REMEDIES FOR GASTRIC ULCER AND GASTROINTESTINAL MOVEMENT DISORDER. | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 2001-05-29 | — | — | US | disclosed |
| EP-0945445-A1 | 1,5-BENZODIAZEPINE DERIVATIVES | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 1999-09-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180244681-A1 | PROCESS | UCHL3, UCHL5, CBR3 | MAPK1 3545/4885 |
| US-10626119-B2 | Process for the preparation of cucurbituril and/or one or more derivatives thereof | UCHL3, UCHL1, UCHL5 | MAPK1 2982/4885 |
| US-10308657-B2 | Composition comprising cucurbituril and/or one or more derivatives thereof | UCHL3, CBR3, UCHL5 | MAPK1 4185/4885 |
| US-20190241579-A1 | PROCESS FOR THE PREPARATION OF CUCURBITURIL AND/OR ONE OR MORE DERIVATIVES THEREOF | UCHL3, UCHL1, UCHL5 | MAPK1 2982/4885 |
| US-20070155676-A1 | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof | APOB, NPC1L1, CYP46A1 | MAPK1 3541/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.